COMMUNIQUÉS West-GlobeNewswire

Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis
26/02/2019
New resources offer important information about the diagnosis process, including the role of advanced lab tests San Diego, CA and Washington, DC, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Exagen, a life science company serving [...]
PotNetwork News Debuts First Issue of Its In-Depth Print Magazine, "PotNetwork”
26/02/2019
Inaugural print issue of the sector's number one news site features exclusive interviews and content with business leaders MIAMI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork News, www.potnetwork.com [...]
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in March
26/02/2019
REDWOOD CITY, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will present at two upcoming investor healthcare conferences. Management will [...]
Chinese-Based MedCDx and US-Based Admera Health Enter Into Strategic Partnership to Co-Develop Companion Diagnostics
26/02/2019
SOUTH PLAINFIELD, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Today, MedCDx and Admera Health announced a non-exclusive collaborative agreement. Under the terms of the agreement, MedCDx (formerly Qiagen Suzhou Translational [...]
NRC Health Hosts 2019 Pediatric Collaborative at Dayton Children’s Hospital
26/02/2019
Industry Leaders Invited to Network, Discuss Unique Challenges Facing Pediatric Healthcare Organizations Today, and Brainstorm Solutions to Solve Them LINCOLN, Neb., Feb. 26, 2019 (GLOBE NEWSWIRE) -- NRC Health , the [...]
Innovate Biopharmaceuticals Schedules Conference Call to Provide Corporate and Operational Progress Updates
26/02/2019
RALEIGH, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics [...]
Marinus Announces Leadership Transition
26/02/2019
RADNOR, Penn., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or the “Company”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat [...]
AXIM® Biotechnologies Announces Successful Microencapsulation of Cannabinoids Into Proprietary Chewing Gum Delivery Mechanism for Clinical Trials
26/02/2019
NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM ® Biotech” or “AXIM”) (OTCQB: AXIM), a world leader in cannabinoid research and development, today announced the company has successfully [...]
VistaGen Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
26/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]
CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 12, 2019
26/02/2019
LAS VEGAS, Feb. 26, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) announced that it will release financial results for its fourth quarter and full year 2018 [...]
Nuvectra® to Present at 39th Annual Cowen Healthcare Conference
26/02/2019
PLANO, Texas, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that Fred Parks, PhD, Chief Executive Officer, and Walter Berger, Chief [...]
PSIQ to Attend and Display at Champs Trade Show, the Premier Counterculture B2B Expo Since 1999 at the Las Vegas Convention Center February 27th, 2019 Through March 1st, 2019
26/02/2019
SUNRISE, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ ) through its subsidiary Elite Products International, Inc. (“Elite”) announces it will be attending and displaying at Champs [...]
Sharps Compliance Adds Sharon R. Gabrielson, Chair of Mayo Clinic’s Global Business Solutions, to Board of Directors
26/02/2019
HOUSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]
SELLAS Life Sciences Announces Review of Strategic Alternatives
26/02/2019
Phase 1/2 basket trial of lead clinical candidate, galinpepimut-S (GPS), plus Keytruda ® (pembrolizumab) ongoing; Phase 3 registrational study for GPS monotherapy in acute myeloid leukemia (AML) planned Discussions on [...]
SpineX Names Scientific Advisory Board to Guide Development of Non-Invasive Medical Devices for Neuromodulation of the Spine
26/02/2019
LOS ANGELES, Feb. 26, 2019 (GLOBE NEWSWIRE) -- SpineX, a developer of non-invasive medical devices to address a broad range of medical conditions through the neuromodulation of the spinal cord to restore function lost [...]
Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the Treatment of Lambert-Eaton Myasthenic Syndrome
26/02/2019
CORAL GABLES, Fla., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Blessing Health System expands Allscripts partnership with clinical and financial solutions
26/02/2019
Health system extends and further expands portfolio to provide integrated platform that includes clinical and financial solutions for both acute and ambulatory settings CHICAGO, Feb. 26, 2019 (GLOBE NEWSWIRE) -- [...]
Protech Home Medical Releases Q1 2019 Results; Posts Revenue Growth of 17% and Adjusted EBITDA Growth of 186% Year Over Year
26/02/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Immutep to Present at Upcoming Industry Conferences
26/02/2019
SYDNEY, Australia, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Pages